ARG Optimizes Clinical Studies with Veeva Vault eTMF & Veeva Vault CTMS
ARG and Veeva recently collaborated on a case study that focuses on improving trial execution and visibility with Veeva Vault eTMF and Veeva Vault CTMS.Key…
Pivotal Phase III trial undergoes audits by the FDA and sponsor
Challenge: A pivotal Phase III clinical trial of C1 inhibitor for the prophylactic treatment of hereditary angioedema managed by ARG successfully underwent 3 investigative site…
ARG successfully starts up a Phase II trial within 6 weeks
Challenge: In an economic downturn, small biotech companies often depend on clinical milestones in order to maximize shareholder value and drive market direction. This means…
ARG rescues Phase I oncology trial using TrialVista® CTMS
Challenge: A leading specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases was mired in an…
Preferred Provider Status for Atlantic Research Group
Challenge: A specialty biopharmaceutical company targeting the therapeutic power of plasma for the treatment of chronic, life-altering diseases like hemophilia and immune deficiencies, contracted with…